PDCD1 and renal cell carcinoma: Similarly, in renal cell carcinoma, lower levels of Bacteroidia in serum EVs were associated with a lower abundance of tumor-infiltrating Tregs, contributing to the enhanced therapeutic efficacy of anti-PD-1 therapy [21].